The Australian Gonococcal Surveillance Programme 1979–2017
Monica M Lahra A B F , CR Robert George A C and David M Whiley D E
+ Author Affiliations
- Author Affiliations
A WHO Collaborating Centre for STD, Microbiology Department, New South Wales Health Pathology East, Prince of Wales Hospital, Sydney, NSW 2031, Australia
B School of Medical Sciences, The University of New South Wales, Sydney, NSW 2052, Australia
C Centre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology, Sydney, NSW, Australia
D Faculty of Medicine, UQ Centre for Clinical Research, The University of Queensland, Herston, Qld 4029, Australia
E Pathology Queensland, Microbiology Department, Herston, Qld 4029, Australia
F Email: Monica.Lahra@health.nsw.gov.au
Microbiology Australia 38(4) 175-179 https://doi.org/10.1071/MA17062
Published: 2 November 2017
Abstract
Neisseria gonorrhoeae (NG) is an important human bacterial pathogen responsible for more than 78million infections per annum globally1. In Australia and elsewhere, NG infection rates are increasing and, critically, antimicrobial resistance (AMR) in NG poses a substantial threat to health security2. In response, the Australian Gonococcal Surveillance Programme (AGSP) was established in 1979, and has steadfastly evolved since that time to meet the challenges of continuously emerging AMR (Figure 1).
References
[1] World Health Organization (2016) Sexually transmitted infections (STIs). http://www.who.int/mediacentre/factsheets/fs110/en/ (accessed 30 August 2017).[2] Wi, T. et al. (2017) Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action. PLoS Med. 14, e1002344.
| Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action.Crossref | GoogleScholarGoogle Scholar |
[3] Craib, K.J. et al. (1995) Rectal gonorrhoea as an independent risk factor for HIV infection in a cohort of homosexual men. Sex. Transm. Infect. 71, 150–154.
| Rectal gonorrhoea as an independent risk factor for HIV infection in a cohort of homosexual men.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2Mzmt1altQ%3D%3D&md5=e2e8c95ba07d8892d0f5478f63b369d5CAS |
[4] Goire, N. et al. (2014) Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance. Nat. Rev. Microbiol. 12, 223–229.
| Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2cXitFamtbw%3D&md5=ccd36db6b924c3611a4f0f62500612f3CAS |
[5] World Health Organization (2016) WHO guidelines for the treatment of Neisseria gonorrhoeae.
[6] Ohnishi, M. et al. (2011) Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob. Agents Chemother. 55, 3538–3545.
| Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXos1Ortbc%3D&md5=f15a57a952925d46f8688714eb03ac4fCAS |
[7] Unemo, M. et al. (2012) High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob. Agents Chemother. 56, 1273–1280.
| High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XjsVKlsL8%3D&md5=6d09e3fa70803c4c4278ab5e3d663e1dCAS |
[8] Lahra, M.M. et al. (2014) A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia. N. Engl. J. Med. 371, 1850–1851.
| A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia.Crossref | GoogleScholarGoogle Scholar |
[9] Ison, C.A. et al. (2013) Current and future treatment options for gonorrhoea. Sex. Transm. Infect. 89, iv52–iv56.
| Current and future treatment options for gonorrhoea.Crossref | GoogleScholarGoogle Scholar |
[10] World Health Organization (2014) Antimicrobial resistance: global report on surveillance. Geneva, Switzerland.
[11] Tapsall, J.W. et al. (1984) Penicillin sensitivity of gonococci in Australia: development of Australian Gonococcal Surveillance Programme. Members of the Australian Gonococcal Surveillance Programme. Br. J. Vener. Dis. 60, 226–230.
[12] Tapsall, J.W. (1990) Use of a quality assurance scheme in a long-term multicentric study of antibiotic susceptibility of Neisseria gonorrhoeae. Genitourin. Med. 66, 8–13.
| 1:STN:280:DyaK3c7osFKrtQ%3D%3D&md5=55e108cef64b65dd8878e6fd9cecb528CAS |
[13] Australian Gonococcal Surveillance Programme (1981) Gonococcal surveillance – Australia (July–September 1981). Commun. Dis. Intell. 25, 2–3.
[14] The Kirby Institute (2016) HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2016. https://kirby.unsw.edu.au/sites/default/files/kirby/report/SERP_Annual-Surveillance-Report-2016_UPD170627.pdf
[15] Speers, D.J. et al. (2014) Non-culture Neisseria gonorrhoeae molecular penicillinase production surveillance demonstrates the long-term success of empirical dual therapy and informs gonorrhoea management guidelines in a highly endemic setting. J. Antimicrob. Chemother. 69, 1243–1247.
| Non-culture Neisseria gonorrhoeae molecular penicillinase production surveillance demonstrates the long-term success of empirical dual therapy and informs gonorrhoea management guidelines in a highly endemic setting.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2cXls1OgtLs%3D&md5=eefab7fdc5fe0271cec2ace7e41aa137CAS |
[16] Lahra, M.M. (2015) Australian Gonococcal Surveillance Programme. Australian Gonococcal Surveillance Programme annual report, 2013. Commun. Dis. Intell. Q. Rep. 39, E137–E145.
[17] Lahra, M.M. and Enriquez, R.P. () Australian Gonococcal Surveillance Programme. Annual report 2016. Commun. Dis. Intell., , .
[18] Lahra, M.M. and Enriquez, R.P. () Australian Gonococcal Surveillance Programme. Gonococcal surveillance – Australia (April–July 2017). Commun. Dis. Intell., , .
[19] Goire, N. et al. (2011) Enhancing gonococcal antimicrobial resistance surveillance: a real-time PCR assay for detection of penicillinase-producing Neisseria gonorrhoeae by use of noncultured clinical samples. J. Clin. Microbiol. 49, 513–518.
| Enhancing gonococcal antimicrobial resistance surveillance: a real-time PCR assay for detection of penicillinase-producing Neisseria gonorrhoeae by use of noncultured clinical samples.Crossref | GoogleScholarGoogle Scholar |
[20] Buckley, C. et al. (2016) A real-time PCR assay for direct characterization of the Neisseria gonorrhoeae GyrA 91 locus associated with ciprofloxacin susceptibility. J. Antimicrob. Chemother. 71, 353–356.
| A real-time PCR assay for direct characterization of the Neisseria gonorrhoeae GyrA 91 locus associated with ciprofloxacin susceptibility.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC28XjslWjtL4%3D&md5=a1cb1a6e9cba10e565c27e5124ed7900CAS |
[21] Trembizki, E. et al. (2015) Direct real-time PCR-based detection of Neisseria gonorrhoeae 23S rRNA mutations associated with azithromycin resistance. J. Antimicrob. Chemother. 70, 3244–3249.
| 1:CAS:528:DC%2BC2MXitVyku77J&md5=39bb6bfecdb3b90f812d55be6ebeb592CAS |
[22] Whiley, D.M. et al. (2017) Molecular antimicrobial resistance surveillance for Neisseria gonorrhoeae, Northern Territory, Australia. Emerg. Infect. Dis. 23, 1478–1485.
| Molecular antimicrobial resistance surveillance for Neisseria gonorrhoeae, Northern Territory, Australia.Crossref | GoogleScholarGoogle Scholar |
[23] Trembizki, E. et al. (2016) The molecular epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in Australia: a nationwide cross-sectional study, 2012. Clin. Infect. Dis. 63, 1591–1598.
| The molecular epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in Australia: a nationwide cross-sectional study, 2012.Crossref | GoogleScholarGoogle Scholar |
